​

Cytosorbents Ownership | Who Owns Cytosorbents?


OverviewForecastRevenueFinancialsChartTranscripts

Cytosorbents Ownership Summary


Cytosorbents is owned by 8.60% institutional investors, 16.25% insiders, and 75.15% retail investors. Avenir is the largest institutional shareholder, holding 8.23% of CTSO shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.08% of its assets in Cytosorbents shares.

CTSO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCytosorbents8.60%16.25%75.15%
SectorHealthcare Stocks 129.28%12.06%-41.34%
IndustryMedical Device Stocks53.50%12.35%34.15%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Avenir259.09K8.23%$1.01M
Vanguard group2.20M3.51%$1.41M
Blackrock655.80K1.21%$461.03K
Neuberger berman group10.42K0.33%$41.67K
Cibc private wealth group172.65K0.28%$110.36K
Northern trust92.54K0.15%$52.41K
Raymond james financial services advisors60.59K0.11%$42.59K
Raymond james & associates50.00K0.09%$35.15K
Goldman sachs group43.95K0.07%$24.89K
Bank of america corp /de/34.45K0.06%$24.22K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Avenir259.09K0.12%$1.01M
Two sigma securities15.74K0.00%$14.70K
Country club bank /gfn15.22K0.00%$14.09K
Xtx topco35.57K0.00%$20.14K
Cibc private wealth group172.65K0.00%$110.36K
Raymond james financial services advisors60.59K0.00%$42.59K
Your advocates ltd., llp---
Merit financial group---
Bradley foster & sargent inc/ct---
N.e.w. advisory services---

Top Buyers

HolderShares% AssetsChange
Two sigma securities15.74K0.00%15.74K
Goldman sachs group43.95K-8.00K
Xtx topco35.57K0.00%5.89K
Comerica bank4.38K-819.00
Royal bank of canada1.10K-300.00

Top Sellers

HolderShares% AssetsChange
Avenir259.09K0.12%-4.93M
Neuberger berman group10.42K--1.96M
Vanguard capital management---1.91M
Cm management---1.48M
Skylands capital---1.21M

Sold Out

HolderChange
Sbi securities-1.00
Qube research-1.00
Bnp paribas arbitrage, snc-3.00
Farther finance advisors-6.00
Pnc financial services group-31.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20263-94.12%270,586-98.32%81.30%1-95.00%2-84.62%
Jun 30, 2026512.00%16,137,911-2.02%253.73%205.26%138.33%
Mar 31, 202638-25.49%15,158,722-10.11%243.37%15-34.78%9-10.00%
Dec 31, 202538-22.45%16,197,322-1.88%253.71%17-22.73%8-20.00%
Sep 30, 2025489.09%16,334,989-0.63%263.78%22100.00%10-44.44%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.30M2.08%-
Vanguard Total Stock Mkt Idx Inv1.27M2.03%-
Vanguard Morn Total Stk Mkt Idx Investor1.27M2.03%-
Vanguard MStar Total Stk Mkt Idx Invest63.72K2.02%-
M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc763.50K1.40%-101.78K
Neuberger Berman Intrinsic Value I674.87K1.08%-
Neuberger Intrinsic Value I32.33K1.03%-1.00
Vanguard Institutional Extnd Mkt Idx Tr574.46K0.91%-
Fidelity Extended Market Index14.48K0.46%-55.00
iShares Micro-Cap ETF144.52K0.23%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 15, 2026Chan Phillip P. Chief Executive OfficerBuy$22.64K
Sep 14, 2026Capponi Vincent President and COOBuy$10.93K
Sep 14, 2026Capponi Vincent President and COOBuy$1.61K
Sep 15, 2026Sobel Alan D.-Buy$601.00
Sep 15, 2026Sobel Alan D.-Buy$3.02K

Insider Transactions Trends


DateBuySell
2026 Q37-
2026 Q23-
2025 Q4--
2025 Q3--
2025 Q1--

CTSO Ownership FAQ


Who Owns Cytosorbents?

Cytosorbents shareholders are primarily institutional investors at 8.60%, followed by 16.25% insiders and 75.15% retail investors. The average institutional ownership in Cytosorbents's industry, Medical Device Stocks, is 53.50%, which Cytosorbents falls below.

Who owns the most shares of Cytosorbents?

Cytosorbents’s largest shareholders are Avenir (259.09K shares, 8.23%), Vanguard group (2.2M shares, 3.51%), and Blackrock (655.8K shares, 1.21%). Together, they hold 12.95% of Cytosorbents’s total shares outstanding.

Does Blackrock own Cytosorbents?

Yes, BlackRock owns 1.21% of Cytosorbents, totaling 655.8K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 461.03K$. In the last quarter, BlackRock decreased its holdings by -66.63K shares, a -9.22% change.

Who is Cytosorbents’s biggest shareholder by percentage of total assets invested?

Avenir is Cytosorbents’s biggest shareholder by percentage of total assets invested, with 0.12% of its assets in 259.09K Cytosorbents shares, valued at 1.01M$.

Who is the top mutual fund holder of Cytosorbents shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Cytosorbents shares, with 2.08% of its total shares outstanding invested in 1.3M Cytosorbents shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools